AVTXVSGOSS• 3 Months (Normalized)
AVTX vs GOSS (Avalo Therapeutics Inc. vs Gossamer Bio Inc.)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.18
+12.91%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
GOSS Performance $10.7
+6269.05%
Gossamer Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
-6256.14%
GOSS outperforming by 6256.14%
AVTXGOSS
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX GOSS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | AVTX Price | AVTX Gain (%) | GOSS Price | GOSS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $16.18 | +12.91% | $10.70 | +6269.05% | -6256.14% |
| Sep 11, 2026 | $16.12 | +12.49% | $10.73 | +6286.90% | -6274.41% |
| Sep 10, 2026 | $17.18 | +19.89% | $11.36 | +6661.90% | -6642.01% |
| Sep 09, 2026 | $18.21 | +27.08% | $12.80 | +7519.05% | -7491.97% |
| Sep 08, 2026 | $19.71 | +37.54% | $14.40 | +8471.43% | -8433.89% |
| Sep 04, 2026 | $19.23 | +34.19% | $14.00 | +8233.33% | -8199.14% |
| Sep 03, 2026 | $19.00 | +32.59% | $14.05 | +8261.90% | -8229.31% |
| Sep 02, 2026 | $19.34 | +34.96% | $0.17 | +2.98% | +31.98% |
| Sep 01, 2026 | $18.95 | +32.24% | $0.17 | -0.60% | +32.84% |
| Aug 31, 2026 | $19.34 | +34.96% | $0.17 | +1.19% | +33.77% |
| Aug 28, 2026 | $19.59 | +36.71% | $0.17 | +1.19% | +35.52% |
| Aug 27, 2026 | $20.05 | +39.92% | $0.17 | +1.19% | +38.73% |
| Aug 26, 2026 | $20.55 | +43.41% | $0.17 | +3.57% | +39.84% |
| Aug 25, 2026 | $19.74 | +37.75% | $0.21 | +22.02% | +15.73% |
| Aug 24, 2026 | $19.27 | +34.47% | $0.18 | +4.17% | +30.30% |
Page 1 of 5